⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3412689 | 0.62 | — | — | |
| SCHEMBL4548057 | 0.62 | — | — | |
| SCHEMBL1416539 | 0.62 | — | — | |
| SCHEMBL268403 | 0.59 | — | — | |
| SCHEMBL20384146 | 0.59 | — | — | |
| SCHEMBL19457042 | 0.59 | — | — | |
| SCHEMBL10028832 | 0.59 | — | — | |
| SCHEMBL5426881 | 0.59 | — | — | |
| SCHEMBL13442812 | 0.59 | — | — | |
| SCHEMBL10457097 | 0.59 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2507272-A1 | METHYLENE AMINOETHYL SULFONIC ACID CHELATING RESINS | Lanxess Deutschland GmbH (DE) | 2012-10-10 | — | — | EP | claimed |
| WO-2011067340-A1 | METHYLENE AMINOETHYL SULFONIC ACID CHELATING RESINS | LANXESS DEUTSCHLAND GMBH (DE) | 2011-06-09 | — | — | WO | claimed |
| US-9079177-B2 | Methylene aminoethyl sulfonic acid chelating resins | LANXESS DEUTSCHLAND GMBH (DE) | 2015-07-14 | — | — | US | disclosed |
| US-20130139649-A1 | METHYLENE AMINOETHYL SULFONIC ACID CHELATING RESINS | LANXESS DEUTSCHLAND GMBH (DE) | 2013-06-06 | — | — | US | disclosed |
| EP-2507272-A1 | METHYLENE AMINOETHYL SULFONIC ACID CHELATING RESINS | Lanxess Deutschland GmbH (DE) | 2012-10-10 | — | — | EP | disclosed |
| WO-2011067340-A1 | METHYLENE AMINOETHYL SULFONIC ACID CHELATING RESINS | LANXESS DEUTSCHLAND GMBH (DE) | 2011-06-09 | — | — | WO | disclosed |
| US-20030144249-A1 | Use of organophosphorous compounds for producing a medicament for treating infections | JOMAA PHARMAKA GMBH (DE) | 2003-07-31 | — | — | US | disclosed |
| WO-2002078714-A1 | FORMULATIONS WHICH ARE RESISTANT TO GASTRIC JUICE AND ARE USED TO APPLY ANTI-INFECTIVE COMPOUNDS INHIBITING THE 2-C-METHYLERYTHROSE-4 METABOLIC PATHWAY, AND THE SALTS AND ESTERS OF THE SAME | JOMAA PHARMAKA GMBH (DE) | 2002-10-10 | — | — | WO | disclosed |
| EP-1100510-A2 | COMBINED PREPARATION OF ANTI-INFECTIOUSLY ACTIVE COMPOUNDS WHICH INHIBIT THE 2-C-METHYLERYTHROSE-4 METABOLIC PATHWAY, AND INHIBITORS OF LIPID METABOLISM | Jomaa, Hassan (DE) | 2001-05-23 | — | — | EP | disclosed |
| WO-1999066875-A2 | COMBINED PREPARATION OF ANTI-INFECTIOUSLY ACTIVE COMPOUNDS WHICH INHIBIT THE 2-C-METHYLERYTHROSE-4 METABOLIC PATHWAY, AND INHIBITORS OF LIPID METABOLISM | JOMAA HASSAN (DE) | 1999-12-29 | — | — | WO | disclosed |